Biggest News Aggregation in the World
๐Ÿ“ฐ Mtama News

Page 4 - Mtama News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Mtama. Real-time updates on events, politics, business and more.

Dermavant Sciences: Dermavant Completes Enrollment of Two Phase 3 Clinical Trials of VTAMA (tapinarof) cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children as Young as 2 years old

- ADORING 1 and 2 trials evaluating VTAMA cream in atopic dermatitis fully enrolled, with topline data expected from the first study in March 2023 and the second study in May 2023 - Dermavant recently
United States Laurence Watts Angela Salerno Robin Todd Zavodnick Roivant Sciences National Prescription Audit

Dermavant Sciences, Inc.: Dermavant to Present Data from Multiple Studies of VTAMA (tapinarof) cream, 1% at the 2023 Winter Clinical Dermatology Conference

- Seven posters will include clinical data for VTAMA cream for the treatment of plaque psoriasis in adults and atopic dermatitis (AD), including data from the successful pediatric maximum usage study
United States Laurence Watts Christopherem Griffiths Holly Glover Stephenc Piscitelli Philipm Brown

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Dermavant Sciences: Dermavant to Present Data from Multiple Clinical Trials of VTAMA (tapinarof) cream, 1% at the 2022 Fall Clinical Dermatology Conference

- Five posters will highlight clinical data for VTAMA cream for the treatment of plaque psoriasis in adults and for atopic dermatitis in patients as young as two - Dermavant Sciences, a biopharmaceutical
United States Las Vegas Laurence Watts Christopherem Griffiths Mark Lebwohl Stephenc Piscitelli

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science